(Q39128082)

English

The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma

scientific article published on June 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

stem cell transplantation

1 reference

based on heuristic

inferred from title

Angela Dispenzieri

12

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

4

object named as

Litzow MR

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

2

object named as

Gertz MA

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

11

object named as

Lacy MQ

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

author name string

Porrata LF

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Geyer SM

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Gastineau DA

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Moore SB

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Pineda AA

7

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Bundy KL

8

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Padley DJ

9

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Persky D

10

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Snow DS

13

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Markovic SN

14

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1085-1092

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403341

0 references

Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403341

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403341

21 January 2018

Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergrou

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403341

21 January 2018

Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403341

21 January 2018

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403341

21 January 2018

Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403341

21 January 2018

Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403341

21 January 2018

Re-infused autologous graft natural killer cells correlates with absolute lymphocyte count recovery after autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403341

21 January 2018

Regression of engineered myeloma cells secreting interferon-gamma-inducing factor is mediated by both CD4(+)/CD8(+) T and natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403341

21 January 2018

Anti-myeloma activity of natural killer lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403341

21 January 2018

Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403341

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403341

7 January 2021

based on heuristic

inferred from DOI database lookup

Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403341

7 January 2021

based on heuristic

inferred from DOI database lookup

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403341

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403341

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune reconstitution after transplantation of autologous peripheral CD34+ cells: analysis of predictive factors and comparison with unselected progenitor transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403341

7 January 2021

based on heuristic

inferred from DOI database lookup

Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403341

7 January 2021

based on heuristic

inferred from DOI database lookup

CD34+-selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: tumour cell contamination and outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403341

7 January 2021

based on heuristic

inferred from DOI database lookup

Reinfusion of autologous lymphocytes with granulocyte-macrophage colony-stimulating factor induces rapid recovery of CD4+ and CD8+ T cells after high-dose chemotherapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403341

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased expression of natural-killer-associated and activation antigens in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403341

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403341

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39128082&oldid=1808879487"